Meetings | NITAG RESOURCE CENTER

08:45 - 09:00

Introduction, agenda presentation, expectations pulse (Mario Melgar)

09:00 - 09:30

Official opening talks followed by group photo

09:30 - 09:45

Global indicators and trends for NITAGs (Laure Dumolard & Louise Henaff)

09:45 - 10:30

Report on GNN activities (Mario Melgar & Louise Henaff)

11:00 - 11:30

Regional Approaches to NITAG Capacity Building (Mimi Lhamu)

Vaccinology course for NITAGs (Tony Hawkridge)
Use of NMAT in the EMRO region (Gerald Sume + Adel Salman Alsayyad)

11:30 - 12:30

Regional updates (Louise Henaff)

13:30 - 14:00

Country gallery walk

14:00 - 15:00

Maximize health impact within available resources: the case for VPOP (Vaccine Program Optimization)

SAGE recommendations, global context, toolkit overview (Johanna Fihman)
GAVI 6.0: country vaccine budget (Marta Tufet)

15:00 - 15:40

Optimization – country examples (Hushendree Naicker)

Maximizing Health Impact with Smart Investments: Iraq’s Success in Vaccine Cost Optimization (Kamal A. Kadhim)
Toward Evidence-Informed Decision-Making for Sustainable Immunization Financing: The Case of Malaria Vaccines (Alex Adjagba)

16:00 - 17:00

Prioritization of new vaccine introductions – country examples (Mario Melgar)

Iran (Sussan Mahmoody)
Ethiopia (Solomon Tessema Memirie)
Canada (Matthew Tunis)

17:00 - 17:30

Available tools for NITAG strengthening: shark tank (Wan Abdul Hannan Wan Ibadullah)

NMAT
EVIDA tools
CDS tool, EUVABECO project

08:30 - 08:45

Opening of the meeting

08:45 - 09:30

The future of immunization policies and practices (Matthew Tunis)

Online Presentation by Kate O’Brien followed by discussion

09:30 - 10:30

Future SAGE policy recommendations and methods (Mario Melgar)

Presentation from Annelies Wilder-Smith & Anthony Scott

11:00 - 12:00

RSV (Awnish Singh)

Maternal vaccine (Angela Gentile, Argentina)
Monoclonal antibody programme in Germany (Ole Wichmann, Germany)
Australia running both programmes (Katherine Gibney, Australia)

12:00 - 12:30

NITAG Secretariat survey report (Wan Abdul Hannan Wan Ibadullah)

Report from the secretariat study (Yuanfei Huang, NCIRS)

13:30 - 14:00

Country gallery walk

14:00 - 14:45

Role of NITAGs in PHEIC (Public Health Emergency of International Concern): Mpox (Nhamo Gonah)

DRC (Abdon Mukalay)
Uganda (Prof Meya)

14:45 - 15:30

Off-label recommendations (Adel Salman Alsayyad)

UK PCV 1+1 (Jenna Gritzfeld)

16:00 - 17:00

Vaccines in the next 5 years (Matthew Tunis)

Overview of vaccine priorities and pipeline (Erin Sparrow & Saskia Den Boon)
Prioritization of novel combination vaccines for children under 5 (Mateusz Hasso- Agopsowicz)
Q&A

08:30 - 08:45

Opening of the meeting

08:45 - 09:45

NITAGs twinnings and collaboration (Mimi Lhamu)

CITAG and Pacific islands (Tracy Evans-Gilbert)
Rabies protocol (NACI – STIKO) (Matthew Tunis)
Twinning experience
ECDC joint systematic reviews (Kate Olsson)

09:45 - 10:45

NITAG maintaining confidence in immunization policies (Hushendree Naicker)

Presentation (Lisa Menning)
Plenary discussion

11:15 - 12:30

Infectious diseases modelling (Adel Salman Alsayyad)

WHO guidance (Sim Yo Soon)
How the JCVI formed advice for a UK gonococcal vaccination programme (Helena Bird)
The example of the updated French vaccination strategy against invasive meningococcal disease (Roland Andrianasolo)

13:30 - 14:15

Workplan and priority activities for the network (Louise Henaff & Mario Melgar)

14:15 - 15:00

NITAGs & Health Technology Assessment (HTA) (Andrew Earnshaw)

Presentation (Edwine Barasa)
Panel discussion with representatives from France (Diane Lastennet and Laurène Peckeu-Abboud), Australia (Allison Cairns), Chile (Vivian Luchsinger Farias)

15:00 - 15:30

Forward looking session (Wan Abdul Hannan Wan Ibadullah)

AI potential to facilitate NITAG work (Matthew Tunis)

15:30 - 16:00

Feedback on workplan for 2026 - 2027 (Louise Henaff & Mario Melgar)

16:00 - 16:30

Conclusion & Closing